Oncology
Irene Ghobrial, M.D.
Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School
Irene Ghobrial, MD, is a hematologist-oncologist at Dana-Farber Cancer Institute in Boston, specializing in hematologic malignancies, particularly multiple myeloma, Waldenström’s macroglobulinemia, and their precursor conditions such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma. As Senior Vice President for Experimental Medicine and Director of the Center for Early Detection and Interception of Blood Cancers, she leads efforts to prevent disease progression
30+
Years in Practice
Credentials
Board Certifications
- Hematology, 2004
- Medical Oncology, 2004
- Internal Medicine, 2001
Education & Training
- Cairo University School of Medicine — M.D., 1995
- Mayo Clinic College of Medicine — Fellowship, Hematology/Oncology
- Wayne State University — Residency, Internal Medicine
Recognition & Leadership
Awards & Honors
- Jan Gosta Waldenstrom Award, International Workshop on Waldenstrom's Macroglobulinemia
- National Cancer Institute Outstanding Investigator Award
- William Dameshek Prize, American Society of Hematology
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
- Lahey Hospital & Medical Center
Languages
English
Experience
30+ years in practice